AI + gene therapy: Roche exercises option to license an AI-designed AAV capsid, providing further validation for the rapid productivity of Dyno Therapeutics, Inc.’s gene delivery engine. 🚚🧬

AI + biomanufacturing: Novo Nordisk licenses Asimov’s CHO Edge System for biologics production.

Congratulations to IDRx and GSK for joining forces. This acquisition represents a pivotal moment in the journey to address a significant unmet need for the treatment of gastrointestinal stromal tumors (GIST). idrx.com/resources/gsk-…

It’s been a tough few weeks. My 10yo daughter was diagnosed with a very rare, aggressive cancer called interdigitating dendritic cell sarcoma (IDCS). I’m reaching out to identify clinicians/patients who have encountered pediatric IDCS, indeterminate dendritic cell histiocytosis

We have a position open for an ML Scientist role to take part in one of the most ambitious undertakings in AI-driven protein design. If you have worked on frontier models (in or outside biology), or protein design, join us and find out. dynotx.com/careers/?gh_ji…

Don’t miss our co-founder Sam Sinai’s talk at #GTC2025! Sam will share Dyno’s latest progress on LEAP—our technology bridging foundation models and therapeutic impact—and demo DynoFold, a new AI model powered by NVIDIA AI that efficiently predicts protein dynamics directly from

“Noventa minuti en el Bernabéu son molto longo.” wsj.com/sports/soccer/…

Be sure to catch Dyno at #SynBioBeta2025 next week! Our CEO & Cofounder Eric Kelsic will be giving a talk and speaking on a panel highlighting what is possible at the intersection of AI and gene therapy, and what this means for the future of human health.

Yes we need to control costs and reduce healthcare spend. But when it comes to drug pricing policy, beware of unwanted side effects: “Most Favored Nation” may mostly disfavor innovation. 🇺🇸 💊🧬

TOMORROW: Join us at this year’s #ASGCT25 Dyno Symposium! Dyno CEO & Cofounder Eric Kelsic will share data on leading-edge AAV capsids, the frontier AI models behind their design, and how Dyno supports partners rapidly advancing next-generation gene therapies into the clinic.

New a16z podcast: Arif Nathoo, co-founder & CEO of Komodo Health. Arif Nathoo shares w/ Jorge Conde & me how Komodo built the most comprehensive healthcare data map: 🗺️ [0:37] Building Komodo from scratch: the vision behind a comprehensive healthcare map 🇺🇸 [1:31] What's

A 9 month-old baby boy with a fatal genetic disease was healed with the 1st-ever personalized n-of-1 gene-editing therapy. We live in an era of medical marvels.

Bet on the future. a16z LP Summit 2025.

🚨NYC folks! Come join us for a fireside chat (and networking session) on the next frontiers of AIxBio between NVIDIA 's Anthony Costa and Dyno Therapeutics, Inc.'s Eric Kelsic (he/him) on June 3rd as a part of #NYTechWeek (info linked below👇) RSVP early as space is filling up fast.